Hardman & Co FY’18 – focus on PTSD drug development 3 September 2018 http://www.hardmanandco.com/docs/de...09.18-fy18-focus-on-ptsd-drug-development.pdf
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025